2,5-Dimethoxy-4-sec-butylamphetamine
| Clinical data | |
|---|---|
| Other names | 2,5-Dimethoxy-4-sec-butylamphetamine; 4-sec-Butyl-2,5-dimethoxyamphetamine; DOSB; DOSBu; 2,5-Dimethoxy-4-(2-butyl)amphetamine; 1-(2,5-dimethoxy-4-(2-butyl)phenyl)-2-aminopropane; 1-DBPAP |
| Routes of administration | Oral |
| Drug class | Serotonin receptor agonist; Serotonergic psychedelic; Hallucinogen |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C15H25NO2 |
| Molar mass | 251.370 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
2,5-Dimethoxy-4-sec-butylamphetamine (DOSB or DOSBu), also known as 1-(2,5-dimethoxy-4-(2-butyl)phenyl)-2-aminopropane (1-DBPAP), is a serotonin receptor modulator of the phenethylamine, amphetamine, and DOx families.